San Francisco femtech startup The Cusp abruptly ceased all operations Dec. 7 after running out of money and failing to raise additional funding, according to the company. In an emailed statement, the company said, "Securing funding during a global pandemic was an insurmountable task." The telemedicine company, which provided hormone testing and primary care for women experiencing menopause symptoms, notified patients that all of The Cusp's features will be disabled as of Dec. 17. Its Twitter and...